Inhibition of Programmed Death Receptor-1/Programmed Death Ligand-1 Interactions by Ginsenoside Metabolites

Evidence suggests that programmed death receptor-1/programmed death ligand-1 (PD-1/PD-L1) targeted inhibitors act as an immune checkpoint blockade, indicating that these compounds may be useful in cancer immunotherapy by inhibiting the immune response between T-cells and tumors. Previous studies hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Yim, Nam-Hui, Kim, Young Soo, Chung, Hwan-Suck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249111/
https://www.ncbi.nlm.nih.gov/pubmed/32365500
http://dx.doi.org/10.3390/molecules25092068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249111/
https://www.ncbi.nlm.nih.gov/pubmed/32365500
http://dx.doi.org/10.3390/molecules25092068

Ejemplares similares